NEW YORK (GenomeWeb News) – BGI has partnered with GENNET, a Prague-based center for genetics, fetal medicine, and assisted reproduction, to offer its non-invasive fetal trisomy test, NIFTY, in the Czech and Slovak Republics.

The NIFTY test uses next-generation sequencing to analyze maternal plasma for fetal aneuploidies including trisomy 21, trisomy 13, and trisomy 18, which cause Down syndrome, Patau syndrome, and Edwards syndrome, respectively.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.

Sep
27
Sponsored by
Philips Genomics

This webinar will present an in-depth look at how Memorial Sloan Kettering Cancer Center has developed and implemented a next-generation sequencing panel for mutational tumor profiling of advanced cancer patients.

Sep
28
Sponsored by
Fabric Genomics

This webinar will discuss the critical role that software can play for clinical labs looking to establish comprehensive genomic testing programs.